| Clinical Characteristic |
Mean ± SEM or proportion |
| NYHA FC III/ IV |
50%/50% |
| EF (%) |
21±1 % |
| LVEDD (mm) |
72± 1.6 |
| LVESD (mm) |
59± 1.8 |
| LA (mm) |
49± 1.2 |
| ICD |
15% |
| ACEI |
65% |
| ARAII |
24% |
| Furosemide |
97% |
| Digoxin |
62% |
| Dbt |
30% |
| BB |
32% |
| Adt |
53% |
| Amiod |
15% |
NYHA FC=New York Heart Assotiation functional class, EF=Ejection Fraction,
LVEDD=Left ventricular end-diastolic diameter, LVESD=Left ventricular endsystolic
diameter, LA = left atrium diameter, ICD= implanted cardiac defibrillator,
ACEI=Angiotensin converting enzyme inhibitors, ARAII=AngiotensinII receptor
antagonists, Dbt=Dobutamine, BB=Beta-Blockers, Adt=Aldosterone-blockers,
Amiod= Amiodarona |
